Eric S. Schweiger
- ASSISTANT CLINICAL PROFESSOR Dermatology
American Board of Dermatology
MD, Albert Einstein College of Medicine
Residency, Internal Medicine
NYU Medical Center
University of Kansas Medical Center
Schweiger ES, Kwasniak L, Aires DJ. Treatment of Dermatosis Papulosa Nigra with a 1064 nm Nd:YAG laser: Report of 2 Cases. Journal of Cosmetic and Laser Therapy 2008 June; 10(2): 120-122.
Schweiger ES. Dalbavancin: a viewpoint by Eric S. Schweiger. Drugs 2008; 68(5): 649-651.
Schweiger ES, Riddle CC, Aiires DJ. Successful Treatment with Injected Hyaluronic acid in a Patient with Lip Assymetry after Surgical Correction of Cleft-lip. Dermatologic Surgery 2008 May; 34 (5): 717-719.
Amin K, Riddle CC, Aires DJ, Schweiger ES. Common and alternate oral antibiotic therapies for acne vulgaris: A Review. Journal of Drugs in Dermatology 2007 September; 6(9): 873-880.
Schweiger ES, Riddle CC, Wernli B, Tonkovic-Capin V. Comparison of Poly-L-Lactic Acid and Calcium Hydroxylapatite for the Treatment of Human Immunodeficiency Virus-Associated Lipoatrophy. Cosmetic Dermatology 2007 May; 20(5): 304-312.
Riddle CC, Amin K, Schweiger ES. Review of Azithromycin for the Treatment of Acne Vulgaris. Cosmetic Dermatology 2007 May; 20(5): 299-302.
Schweiger E, Spann CT, Weinberg JM, Ross B. A Case of Desmoplastic Trichilemmoma of the Lip Treated with Mohs Surgery. Dermatologic Surgery 2004 Jul; 30(7): 1062-1064.
Garzon MC, Schweiger E. Cutis Marmorata Telangiectatica Congenita. Seminars in Cutaneous Medicine and Surgery 2004 June; 23(2): 99-106.
Schweiger ES, Weinberg JM. Novel antibacterial agents for skin and skin structure infections. Journal of the American Academy of Dermatology 2004 March; 50(3): 331-340.
Schweiger ES, Scheinfeld NS, Tishler HR, Weinberg JM. Linezolid and Quinupristin/Dalfopristin: Novel antibiotics for gram-positive infections of the skin. Journal of Drugs in Dermatology 2003 Aug; 2(4): 378-383.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Schweiger is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Icahn Medical Institute Floor 2nd Fl. -Dermatology Room L2-28 (Box 1047)
1425 Madison Avenue
New York, NY 10029
110 East 55th Street
New York, NY 10022
110 East 55th Street
New York, NY 10022
- Monday 9:00am - 6:00pm
- Tuesday 9:00am - 6:00pm
- Wednesday 9:00am - 6:00pm
- Thursday 9:00am - 6:00pm
- Friday 9:00am - 6:00pm
- Aetna Indeminty
- Aetna U.S. Healthcare
- Aetna U.S. Healthcare - HMO
- Best Doctor
- Blue Choice
- Blue Cross/ Blue Shield
- Blue Cross/ Blue Shield - HMO
- Blue Shield Premier - HMO
- Blue Shield Premier
- Blue Shield Wrap Around
- Blue Shield Wrap Around Plus
- Blue Shield Wrap Around Plus - HMO
- Blue Shield of Connecticut
- Blue Shield of Connecticut - HMO
- CIGNA - Indemnity
- Empire Blue Cross/ Blue Shield - HMO
- Empire Blue Cross/Blue Shield
- Empire Plan/UHC
- Group Health Insurance, Inc.
- HIP of New Jersey
- HIP of New Jersey - HMO
- Health Insurance Plan (HIP)
- Health Insurance Plan (HIP) - HMO
- Horizon - Blue Cross Blue Shield
- Horizon - Blue Cross Blue Shield - HMO
- Horizon Healthcare
- Horizon Healthcare - HMO
- MultiPlan, Inc.
- Oxford Health Plans
- United Healthcare
- Master Card
- American Express
- Personal Check